Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
09 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/09/3095725/0/en/SEED-Therapeutics-Appoints-Dr-Bill-Desmarais-as-Chief-Financial-Officer-and-Chief-Business-Officer.html
05 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/05/3073955/0/en/SEED-Therapeutics-Highlights-Breakthrough-Advances-in-Targeted-Protein-Degradation-at-AACR-2025.html
24 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/24/3067294/0/en/SEED-Therapeutics-Reports-Breakthroughs-for-Two-Targeted-Protein-Degradation-Projects-at-AACR-Annual-Meeting-in-Chicago.html
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016234/0/en/SEED-Receives-FDA-Rare-Pediatric-Disease-and-Orphan-Drug-Designations-for-Lead-Oncology-Asset-RBM39-Degrader-and-Enters-Strategic-Transactions-with-New-Investors.html
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016236/0/en/BeyondSpring-Announces-35-4-Million-Sale-of-a-Portion-of-Equity-Interest-in-SEED-Therapeutics-to-Advance-Lead-Asset-Plinabulin-to-Anti-Cancer-Registrational-Studies.html
12 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/12/2945072/0/en/SEED-Therapeutics-Appoints-Eisai-Co-Ltd-s-Dr-Yoshiharu-Mizui-to-Board-of-Directors.html
ABOUT THIS PAGE